🇺🇸 FDA
Patent

US 7524508

Subgenomic replicons of the flavivirus dengue

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 7524508 (Subgenomic replicons of the flavivirus dengue) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/5258, A61K2039/53